Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H11NO |
| Molecular Weight | 101.1469 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC(N)=O
InChI
InChIKey=SANOUVWGPVYVAV-UHFFFAOYSA-N
InChI=1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7)
| Molecular Formula | C5H11NO |
| Molecular Weight | 101.1469 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Isovaleramide (also known as NPS 1776) is one of the active anticonvulsant constituents of Valeriana pavonii, it was suggested, isovaleramide can be a positive allosteric modulator of the GABAA receptor. This drug was studied in clinical trials for the treatment of A migraine, epilepsy and some others CNS disorders, but these studies were discontinued.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2109243 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20890571 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Isovaleramide, an anticonvulsant molecule isolated from Valeriana pavonii]. | 2009-11-05 |
|
| N-[6-(Dibromo-meth-yl)-2-pyrid-yl]-2,2-dimethyl-propionamide. | 2009-03-11 |
|
| Modifications of antiepileptic drugs for improved tolerability and efficacy. | 2008-02-14 |
|
| The effectiveness of anticonvulsants in psychiatric disorders. | 2008 |
|
| New antiepileptic drugs that are second generation to existing antiepileptic drugs. | 2006-06 |
|
| Diverse mechanisms of antiepileptic drugs in the development pipeline. | 2006-06 |
|
| Mass spectral characterization of fatty acid amides from alfalfa trichomes and their deterrence against the potato leafhopper. | 2005-03 |
|
| Could valerian have been the first anticonvulsant? | 2004-11 |
|
| New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet? | 2003-04 |
|
| Synthesis of N4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine analogues. n-Butyramide, 3-chloropropionamide, 3-aminopropionamide, and isovaleramide analogues. | 2001-04-23 |
|
| [Effect of some ADH inhibitors on microsomal alcohol oxidizing system activity in vitro]. | 2001 |
|
| Insight to structural subsite recognition in plant thiol protease-inhibitor complexes : understanding the basis of differential inhibition and the role of water. | 2001 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00172094
single oral dose 400 mg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20890571
isovaleramide (300 µM) exhibited a 42% of inhibition of the binding of ³H-FNZ to its sites.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:13:07 GMT 2025
by
admin
on
Mon Mar 31 18:13:07 GMT 2025
|
| Record UNII |
9CP4KB634M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
541-46-8
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
Isovaleramide
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL171066
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
9CP4KB634M
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
208-781-1
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
300000044620
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
m6546
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
C76507
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
RR-08
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
C038165
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
402555
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
DTXSID3060249
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY | |||
|
10930
Created by
admin on Mon Mar 31 18:13:07 GMT 2025 , Edited by admin on Mon Mar 31 18:13:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |